NSC |
Compound |
Enrichment |
Correlation |
NSC 132791 |
Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo |
0.049100146992119 |
0.10482254 |
NSC 133118 |
2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) |
0.049100146992119 |
0.11842703 |
NSC 144163 |
Quinoxaline, 6-chloro-2,3-bis(iodomethyl)- |
0.049100146992119 |
0.19315537 |
NSC 168516 |
Benzene, 1,1'-(1,2-ethanediyl)bis[2,5-dimethoxy- |
0.049100146992119 |
0.3427917 |
NSC 28608 |
Null |
0.049100146992119 |
0.24219078 |
NSC 295272 |
Null |
0.049100146992119 |
0.073241335 |
NSC 319947 |
2,4-Pyrimidinediamine, 5-(3-azido-4-chlorophenyl)-6-ethyl- |
0.049100146992119 |
0.076068015 |
NSC 346098 |
Null |
0.049100146992119 |
0.21727573 |
NSC 55720 |
Phosphinic acid, bis(1-aziridinyl)-, 2-naphthalenyl ester (9CI) |
0.049100146992119 |
0.020972935 |
NSC 618770 |
Piperidin-4-ol, N-ethyl-N-methyl-3-(1-oxo-3-phenyl-2-propen-1-yl)-4-(2-phenylethen-1-yl)-, (E,E)-, bromide |
0.049100146992119 |
0.32377529 |